Predictors of Clinical Outcome in Fibromyalgia After a Brief Interdisciplinary Fibromyalgia Treatment Program: Single Center Experience

被引:16
作者
Oh, Terry H. [1 ]
Hoskin, Tanya L. [6 ]
Luedtke, Connie A. [5 ]
Weingarten, Toby N. [4 ]
Vincent, Ann [3 ]
Kim, Chul H. [1 ,2 ]
Thompson, Jeffrey M. [1 ]
机构
[1] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA
[2] Kyungpook Natl Univ, Sch Med, Dept Rehabil Med, Taegu, South Korea
[3] Mayo Clin, Dept Fibromyalgia & Chron Fatigue, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Pain Rehabil Ctr, Rochester, MN 55905 USA
[6] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
IMPACT; PAIN; SEVERITY; QUESTIONNAIRE; METAANALYSIS; PREVALENCE; ABUSE;
D O I
10.1016/j.pmrj.2011.10.014
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To determine which patient characteristics are closely associated with a positive response to a brief interdisciplinary fibromyalgia treatment program (FTP). Design: A prospective cohort study. Setting: FTP at a tertiary medical center. Participants: A total of 536 patients with a confirmed diagnosis of fibromyalgia who underwent the FTP and completed the Fibromyalgia Impact Questionnaire (FIQ) at baseline and 6-1.2 months after treatment. Interventions: A brief 1.5-day interdisciplinary FTP, which included evaluation with a registered nurse and a physician for a diagnosis or confirmation of fibromyalgia, fibromyalgia education, interactive self management session, and physical and occupational therapy. Main Outcome Measurements: The responder definition was an improvement of 14% or more in the FIQ total score from their baseline to 6-12 months after treatment. Results: Mean (standard deviation) age of our patients was 50.3 +/- 13.0 years; 515 women (96%) and 23 men (4%). Two hundred forty-eight patients (46%) met the responder definition at 6-12 months follow-up. In an univariate analysis, younger age (P = .008), college or higher education (P = .02), fewer tender points (P = .048), and higher FIQ depression subscore (P = .02) significantly predicted positive response. In a multivariate analysis, these factors all remained statistically significant. In addition, a positive abuse history became significant (P = .03). There was no significant association for gender, duration of symptoms, marital status, employment, smoking status, or 3 numeric rating scale pain scores. Conclusions: Patients with younger age, more years of education (with college or graduate degree), higher baseline FIQ depression score, lower tender point count, and absent abuse history experience greater benefit from a brief FTP. PM R 2012;4:257-263
引用
收藏
页码:257 / 263
页数:7
相关论文
共 27 条
[1]   Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire [J].
Bennett, Robert M. ;
Bushmakin, Andrew G. ;
Cappelleri, Joseph C. ;
Zlateva, Gergana ;
Sadosky, Alesia B. .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) :1304-1311
[2]  
BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728
[3]   EULAR evidence-based recommendations for the management of fibromyalgia syndrome [J].
Carville, S. F. ;
Arendt-Nielsen, S. ;
Bliddal, H. ;
Blotman, F. ;
Branco, J. C. ;
Buskila, D. ;
Da Silva, J. A. P. ;
Danneskiold-Samsoe, B. ;
Dincer, F. ;
Henriksson, C. ;
Henriksson, K. G. ;
Kosek, E. ;
Longley, K. ;
McCarthy, G. M. ;
Perrot, S. ;
Puszczewicz, M. ;
Sarzi-Puttini, P. ;
Silman, A. ;
Spaeth, M. ;
Choy, E. H. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (04) :536-541
[4]   Prevalence of abuse in fibromyalgia and other rheumatic disorders at a specialized clinic in rheumatic diseases in Guatemala City [J].
Castro, I ;
Barrantes, F ;
Tuna, M ;
Cabrera, G ;
Garcia, C ;
Recinos, M ;
Espinoza, LR ;
Garcia-Kutzbach, A .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (03) :140-145
[5]  
Creamer P, 1999, J RHEUMATOL, V26, P1785
[6]   The influence of age on fibromyalgia symptoms [J].
Cronan, TA ;
Serber, ER ;
Walen, HR ;
Jaffe, M .
JOURNAL OF AGING AND HEALTH, 2002, 14 (03) :370-384
[7]   THE NATURAL-HISTORY OF FIBROMYALGIA [J].
FELSON, DT ;
GOLDENBERG, DL .
ARTHRITIS AND RHEUMATISM, 1986, 29 (12) :1522-1526
[8]  
Finset A, 2004, J RHEUMATOL, V31, P976
[9]  
Fitzcharles MA, 2003, J RHEUMATOL, V30, P154
[10]  
GOLDENBERG DL, 1995, J RHEUMATOL, V22, P2313